Welcome to our dedicated page for Innovex International SEC filings (Ticker: INVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Innovex International, Inc. filings document formal disclosures for an oil and gas well-products company formed from the Dril-Quip and Innovex Downhole Solutions merger. Recent 8-K reports furnish quarterly results, earnings presentations and non-GAAP reconciliations, while proxy materials cover annual meeting matters, board governance and executive compensation.
The filing record also includes material-event disclosures on common-stock offering agreements by selling stockholders, share repurchase activity under the company's repurchase program, director changes and litigation involving Downhole Well Solutions, LLC, a wholly owned subsidiary, and friction-reduction tools used in directional drilling.
Innovex International, Inc. director Benjamin Matthew Fink reported an equity award of common stock. He acquired 5,465 shares of common stock on a grant/award basis at a stated price of $0.00 per share. Following this award, his directly held common stock position increased to 21,376 shares.
Anderson Adam reported acquisition or exercise transactions in this Form 4 filing.
Innovex International, Inc. reported that Chief Executive Officer Adam Anderson received a grant of 47,438 shares of common stock on February 27, 2026 at a stated price of $0.00 per share. Following this award, he directly owns 514,182 common shares.
Innovex International, Inc. director Jupp Terence Bartlett reported an award of 5,465 shares of common stock on February 27, 2026. The shares were acquired as a grant at a stated price of $0.00 per share, bringing his directly held stake to 89,832 common shares.
Innovex International director Sedita Angie reported a stock grant. On this Form 4, Sedita received 5,465 shares of Innovex International, Inc. common stock as a grant or award at no cost. After this acquisition, Sedita directly holds a total of 29,881 common shares.
Innovex International, Inc. director John Lovoi received a stock award of 5,465 shares of common stock on February 27, 2026, recorded as a grant or other acquisition at a stated price of $0.00 per share. After this award, his directly held common stock ownership increased to 101,427 shares.
Reddout Mark reported acquisition or exercise transactions in this Form 4 filing.
Innovex International, Inc. reported that President of North America Mark Reddout received a grant of 18,975 shares of common stock on February 27, 2026. The award was recorded at a price of $0.00 per share, bringing his directly held common stock to 148,411 shares after the transaction.
Black Bonnie S. reported acquisition or exercise transactions in this Form 4 filing.
Innovex International, Inc. director Bonnie S. Black received a grant of 5,465 shares of common stock on February 27, 2026 at no stated purchase price. Following this award, she directly holds a total of 35,844 common shares.
Reed Kendal reported acquisition or exercise transactions in this Form 4 filing.
Innovex International, Inc. reported that Chief Financial Officer Reed Kendal received a grant of 18,975 shares of common stock on February 27, 2026 as a stock award with no purchase price. Following this award, his directly owned holdings total 217,832 common shares.
Innovex International’s major shareholder group updated its ownership after a large secondary stock sale. Selling stockholders agreed to sell 5,750,000 shares of common stock at $25.75 per share, and the underwriters fully exercised a 30-day option for another 862,500 shares.
The selling stockholders received $24.59125 per share, reflecting underwriting discounts. As part of the same transaction, Innovex repurchased 575,000 of these shares under its existing buyback program. After these moves, Amberjack-related entities and affiliates may be deemed to beneficially own 22,757,322 shares, or 33.2% of the 68,563,690 shares outstanding as of February 27, 2026.
Amberjack-affiliated investment funds sold 6,612,500 shares of Innovex International common stock in an underwritten secondary offering. The shares were sold at a public offering price of $25.75 per share, and the selling funds received $24.59125 per share after underwriting discounts.
The transactions were reported as indirect sales by entities including Amberjack Capital Fund II, Innovex Co-Invest Fund II, Innovex Co-Invest Fund, Intervale Capital Fund II, Intervale Capital Fund II-A, and Intervale Capital Fund III. Footnotes state that Amberjack Management and related general partners may be deemed beneficial owners, while managing partner Jason Turowsky disclaims beneficial ownership beyond his economic interest.